This fact sheet describes PATH's drug development program, including our work to develop new treatments for malaria, kala-azar (visceral leishmaniasis), and diarrheal disease.
Corporate author(s): PATH
Publication date: September 2012
267 KB PDF
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
This publication is part of the series PATH's areas of focus fact sheets
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA